Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months
Clinical trial NCT00200512 · COMPLETED
Trial details
- NCT number
- NCT00200512
- Sponsor
- Mylan Bertek Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-09-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.